Literature DB >> 16878983

Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.

Kimberly L Sciarretta1, Adrienne Boire, David J Gordon, Stephen C Meredith.   

Abstract

In a recent model of beta-amyloid (Abeta) fibrils, based mainly on solid-state NMR data, a molecular layer consists of two beta-sheets (residues 12-23 and 31-40 of Abeta1-40), folded onto one another by a connecting "bend" structure (residues 25-29) in the side-chain dimension. In this paper, we use two N-methyl amino acids to disrupt each of the two beta-sheets individually (2NMe(NTerm), residues 17 and 19; and 2NMe(CTerm), residues 37 and 39), or both of them at the same time (4NMe, with the above four N-methylated residues). Our data indicate that incorporation of two N-methyl amino acids into one beta-sheet is sufficient to disrupt that sheet while leaving the other, unmodified beta-sheet intact and able to form fibrils. We show, however, that disruption of each of the two beta-sheets has strikingly different effects on fibrillogenesis kinetics and fibril morphology. Both 2NMe(NTerm) and 2NMe(CTerm) form fibrils at similar rates, but more slowly than that of unmodified Abeta1-40. Electron microscopy shows that 2NMe(NTerm) forms straight fibrils with fuzzy amorphous material coating the edges, while 2NMe(CTerm) forms very regular, highly twisted fibrils-in both cases, distinct from the morphology of Abeta1-40 fibrils. Both 2NMe peptides show a "CMC" approximately four times greater than that of Abeta1-40. CD spectra of these peptides also evolve differently in time: whereas the CD spectra of 2NMe(NTerm) evolve little over 10 days, those of 2NMe(CTerm) show a transition to high beta-sheet content at about day 4-5. We also show that disruption of both beta-sheet domains, as in 4NMe, prevents fibril formation altogether, and renders Abeta1-40 highly water soluble and monomeric, and with solvent-exposed side chains. In summary, our data show (1) that the two beta-sheet domains fold in a semiautonomous manner, since disrupting each one still allows the other to fold; (2) that disruption of the N-terminal beta-sheet has a more profound effect on fibrillogenesis than disruption of the C-terminal beta-sheet, suggesting that the former is the more critical for the overall structure of the fibril; and (3) that disruption of both beta-sheet domains renders the peptide monomeric and unable to form fibrils.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16878983     DOI: 10.1021/bi0605585

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Replica exchange molecular dynamics of the thermodynamics of fibril growth of Alzheimer's Aβ42 peptide.

Authors:  Ming Han; Ulrich H E Hansmann
Journal:  J Chem Phys       Date:  2011-08-14       Impact factor: 3.488

2.  Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein.

Authors:  Subramaniam Boopathi; Ponmalai Kolandaivel
Journal:  J Mol Model       Date:  2014-02-25       Impact factor: 1.810

3.  Computational backbone mutagenesis of Abeta peptides: probing the role of backbone hydrogen bonds in aggregation.

Authors:  Takako Takeda; Dmitri K Klimov
Journal:  J Phys Chem B       Date:  2010-04-15       Impact factor: 2.991

4.  Structure and dynamics of parallel beta-sheets, hydrophobic core, and loops in Alzheimer's A beta fibrils.

Authors:  Nicolae-Viorel Buchete; Gerhard Hummer
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

Review 5.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  Peptide backbone modification in the bend region of amyloid-β inhibits fibrillogenesis but not oligomer formation.

Authors:  Erik C B Johnson; Jennifer D Lanning; Stephen C Meredith
Journal:  J Pept Sci       Date:  2016-04-26       Impact factor: 1.905

Review 7.  The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease.

Authors:  Justin A Lemkul; David R Bevan
Journal:  ACS Chem Neurosci       Date:  2012-08-27       Impact factor: 4.418

8.  A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects.

Authors:  Fang Wang; Xian-Ling Zhou; Qi-Gang Yang; Wen-Hua Xu; Fei Wang; Yong-Ping Chen; Gui-Hai Chen
Journal:  PLoS One       Date:  2011-11-10       Impact factor: 3.240

9.  Oxidation destabilizes toxic amyloid beta peptide aggregation.

Authors:  J Razzokov; M Yusupov; A Bogaerts
Journal:  Sci Rep       Date:  2019-04-02       Impact factor: 4.379

10.  Peptide backbone modifications of amyloid β (1-40) impact fibrillation behavior and neuronal toxicity.

Authors:  Benedikt Schwarze; Alexander Korn; Corinna Höfling; Ulrike Zeitschel; Martin Krueger; Steffen Roßner; Daniel Huster
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.